Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Open-label, Randomised, Controlled, Parallel Arms Clinical Trial of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone as Neoadjuvant Treatment for Locally Recurrent Rectal Cancer - PelvEx II

NCT04389086 is registered in ClinicalTrials.gov with Catharina Ziekenhuis Eindhoven as lead sponsor.

NCT NCT04389086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04389086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Open-label, Randomised, Controlled, Parallel Arms Clinical Trial of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone as Neoadjuvant Treatment for Locally Recurrent Rectal Cancer - PelvEx II
Lead sponsor
Catharina Ziekenhuis Eindhoven
Phase
Phase 3
Overall status
Recruiting
Start date
November 13, 2020
Completion date
March 1, 2030
Enrollment
364 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent rectal cancer